Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

NSE/MEDISTEP stock hub

NSE/MEDISTEP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MEDISTEPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

312.6M

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MEDISTEP

In the news

Latest news · NSE/MEDISTEP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E5.5

P25 n/aP50 n/aP75 n/a

ROE29.1

P25 n/aP50 n/aP75 n/a

ROIC29.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MEDISTEP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

136

Groups with data

Currency

INR

Showing 136 of 136 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 305.9M
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	INR 312.6M
Price	INR 22
Price currency	INR
Sic	5122
Symbol	nse/MEDISTEP
Website	https://www.medistephc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	13.26%
EV Earnings	7.38x
EV/EBIT	5.49x
EV/EBITDA	5.46x
EV/Sales	0.62x
P/B ratio	1.86x
P/E ratio	5.49x
P/S ratio	0.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.22%
EBITDA Margin	11.28%
Gross margin	12.28%
Gross Profit	INR 61M
Net Income	INR 41.4M
Pretax Margin	11.15%
Profit Margin	8.35%
ROA	18.35
ROCE	33.04
ROE	29.06
ROIC	29.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	27.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 2.62
Assets	INR 229.9M
Cash	INR 13.1M
Current Assets	INR 238.6M
Current Liabilities	INR 100.7M
Debt	INR 6.4M
Debt EBITDA	INR 0.11
Debt Equity	INR 0.04
Equity	INR 168.3M
Interest Coverage	190.7
Liabilities	INR 61.5M
Long Term Assets	INR -8.8M
Long Term Liabilities	INR -39.2M
Net Cash	INR 6.7M
Net Cash By Market Cap	INR 2.16
Net Debt EBITDA	INR -0.12
Net Debt Equity	INR -0.04
Tangible Book Value	INR 168.3M
Tangible Book Value Per Share	INR 16.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.73
Inventory Turnover	43.04
Net Working Capital	INR 160.4M
Quick ratio	3.5
Working Capital	INR 167.1M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	20.73
All Time High	53
All Time High Change	-56.32%
All Time High Date	2025-08-18
All Time Low	16.5
All Time Low Change	40.3%
All Time Low Date	2026-03-30
ATR	0.97
Beta1y	1.03
Ch YTD	0.22
High	22.05
High52	53
High52 Date	2025-08-18
High52ch	-58.49%
Low	22
Low52	16.5
Low52 Date	2026-03-30
Low52ch	33.33%
Ma50ch	11.69%
RSI	56.6
RSI Monthly	0
RSI Weekly	34.97
Sharpe ratio	-1.97x
Sortino ratio	-2.54
Tr YTD	0.22
Tr1m	22.16%
Tr1w	5.23%
Tr3m	1.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 55.7M
Operating margin	11.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,744,000%
Net Borrowing	3,092,000
Shares Insiders	68.96%
Shares Out	14,209,546

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	11,700x
Bv Per Share	16.09
Ch1m	22.16
Ch1w	5.23
Ch3m	1.54
Ch6m	-1.07
Change	-4.97%
Change From Open	0
Close	23.15
Days Gap	-4.97
Depreciation Amortization	321,000
Dollar Volume	330,000
Earnings Date	2026-08-04
EBIT	INR 55.7M
EBITDA	INR 56M
EPS	INR 4.01
F Score	3
Financing CF	12,789,000
Fiscal Year End	March
Founded	2,023
Graham Number	38.09093
Graham Upside	64.54
Income Tax	INR 13.9M
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2024-06-30
Ma20	20.19
Ma20ch	14.67%
Net CF	13,004,000
Next Earnings Date	2026-08-04
Open	22
P OCF Ratio	1,447.3
Position In Range	0
Ppne	1,469,000
Price Date	2026-05-08
Price EBITDA	INR 5.58
Ptbv Ratio	1.86
Relative Volume	1.28x
Revenue	496,548,000x
Tax By Revenue	2.81x
Tax Rate	25.18%
Tr6m	-1.07%
Volume	15,000
Z Score	4.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/MEDISTEP pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/MEDISTEP?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+69.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

NSE/MEDISTEP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MEDISTEP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MEDISTEP stock rating?

nse/MEDISTEP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MEDISTEP analysis?

The full report lives at /stocks/nse/MEDISTEP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MEDISTEP?

The latest report frames nse/MEDISTEP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MEDISTEP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.